Secondary Vasculitis Attributable to Post-COVID Syndrome.

Area of Science:

• Immunology
• Infectious Diseases
• Rheumatology

Background:

• The COVID-19 pandemic has transitioned from acute to chronic phases, revealing long-term health consequences.
• A notable increase in COVID-19-associated vasculitis cases has been observed globally.
• The novel coronavirus (SARS-CoV-2) affects multiple organ systems beyond the lungs, including the nervous, cardiovascular, and renal systems.

Purpose of the Study:

• To review and synthesize existing case reports and data on the association between COVID-19 and vasculitis.
• To explore the potential of COVID-19 to induce specific forms of vasculitis.
• To highlight the need for further research into the diagnosis and treatment of COVID-19-related vasculitis.

Main Methods:

• Literature review of case reports and relevant data.
• Analysis of the pathogenesis of COVID-19-induced vasculitis, focusing on humoral immunity and immune complex disease.
• Discussion of specific vasculitis conditions associated with COVID-19.

Main Results:

• COVID-19 can trigger vasculitis within two weeks of infection or with later onset.
• Evidence suggests a link between COVID-19 and secondary vasculitis.
• Case reports indicate associations with giant cell arteritis, ophthalmic arteritis, aortitis, and Kawasaki-like disease.

Conclusions:

• COVID-19 is increasingly associated with the development of secondary vasculitis.
• Understanding the pathogenesis, including immune complex mechanisms, is crucial.
• More research is imperative for effective diagnosis and management strategies for COVID-19-associated vasculitis.